highperformr logo

Arbor Biotechnologies's Overview

Total employees114
HeadquartersCambridge
Founded2016

Arbor Biotechnologies is a life sciences company at the forefront of discovering and developing novel gene editing technologies. Leveraging a proprietary research engine that integrates machine learning, high-throughput screening, and genome sequencing, Arbor systematically explores nature's diversity to find unique CRISPR-based nucleases and other gene editing tools. Their mission is to create more precise, efficient, and versatile solutions to address a wide range of genetic diseases and advance human health. Arbor focuses on developing both in vivo and ex vivo therapies, aiming to unlock the full potential of genomic medicine.

Where is Arbor Biotechnologies's Headquarters?

HQ Function

The Cambridge headquarters serves as the central hub for Arbor's research and development, discovery platform operations, strategic planning, and corporate functions.

Notable Features:

Situated in a modern life sciences building, the facility likely houses state-of-the-art laboratories equipped for advanced molecular biology, gene editing, protein engineering, and bioinformatics.

Work Culture:

The work culture is characterized by scientific rigor, innovation, collaboration, and a fast-paced, mission-driven environment focused on pioneering new gene editing therapies.

HQ Significance:

Its location in Cambridge provides Arbor with unparalleled access to leading academic institutions (like MIT and Harvard), a dense network of biotech peers, venture capital, and a highly skilled talent pool, fostering collaboration and accelerating discovery.

Values Reflected in HQ: The headquarters embodies Arbor's commitment to scientific excellence, innovation in gene editing, and the pursuit of transformative therapies for patients.

Location:

While Arbor Biotechnologies's primary operations are centered in Cambridge, MA, its research, potential therapies, and collaborations have global implications. The company engages with the international scientific community through publications, conferences, and potential partnerships. Their focus on developing gene editing tools for diseases impacts patient populations worldwide, and they may pursue clinical trials or commercialization on an international scale in the future.

Street Address:

675 W Kendall St

City:

Cambridge

State/Province:

MA

Country:

USA

Arbor Biotechnologies's Global Presence

Buying Intent Signals for Arbor Biotechnologies

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Arbor Biotechnologies

As of April 2025, Arbor Biotechnologies' leadership includes:

Devyn M. Smith, Ph.D. - Chief Executive Officer
David R. Cheng, Ph.D. - Co-founder & Chief Scientific Officer
Paul G. Schmidt, Ph.D. - Chief Operating Officer
Pamela Stetkiewicz, Ph.D., M.B.A. - Chief Financial Officer
Kathryn McCabe, Ph.D. - Chief Business Officer
Daniel R. Anderson, Ph.D. - Chief Technology Officer

Investors of Arbor Biotechnologies

Arbor Biotechnologies has been backed by several prominent investors over the years, including:

ARCH Venture Partners
Temasek
Ally Bridge Group
TCG Crossover
GV (Google Ventures)
Viking Global Investors
Casdin Capital
Vertex Ventures HC
Catalio Capital Management
ArrowMark Partners

Executive New Hires/Exits in the Last 12 Months

Hire2
Exits0

Arbor Biotechnologies strengthened its leadership team with key appointments in early 2023, including a new CFO and CBO. No major executive departures have been widely publicized in the immediate last 12 months.

New Appointments:

Pamela Stetkiewicz, Ph.D., M.B.A., Pamela Stetkiewicz appointed as Chief Financial Officer to drive financial strategy and operations.
Kathryn McCabe, Ph.D., Kathryn McCabe appointed as Chief Business Officer to oversee strategic partnerships and growth initiatives.

Technology (Tech Stack) used by Arbor Biotechnologies

Discover the tools Arbor Biotechnologies uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Arbor Biotechnologies Email Formats and Examples

Common email formats at Arbor Biotechnologies likely include [first_initial][last]@arbor.bio or [first].[last]@arbor.bio. These are standard patterns in the biotech industry.

flast@arbor.bio, first.last@arbor.bio

Format

dsmith@arbor.bio (example based on Devyn Smith)

Example

80%

Success rate

News and media

Lonza Press ReleaseOctober 4, 2023

Arbor Biotechnologies news title: Lonza and Arbor Biotechnologies® Announce CRISPR Gene Editing Technology Licensing Agreement

Lonza, a global manufacturing partner to the pharma, biotech and nutrition industries, and Arbor Biotechnologies (Arbor), a biotechnology company discovering and developing the next generation of genetic medicines, today announced an agreement that provides Lonza with access to Arbor’s CRISPR-based gene editing technology....more

Arbor Biotechnologies Press ReleaseJanuary 10, 2023

Arbor Biotechnologies news title: Arbor Biotechnologies Strengthens Leadership Team with Appointments of Pamela Stetkiewicz, Ph.D., M.B.A. as Chief Financial Officer and Kathryn McCabe, Ph.D. as Chief Business Officer

Arbor Biotechnologies announced the appointments of Pamela Stetkiewicz, Ph.D., M.B.A., as Chief Financial Officer (CFO) and Kathryn McCabe, Ph.D., as Chief Business Officer (CBO), strengthening its executive team to support growth and strategic objectives....more

Arbor Biotechnologies Press ReleaseJuly 28, 2021

Arbor Biotechnologies news title: Arbor Biotechnologies Announces $215 Million Series B Financing to Advance Next-Generation Precision Genetic Medicines

Arbor Biotechnologies announced the successful completion of a $215 million Series B financing round. The funding will be used to advance its portfolio of precision genetic medicines, further develop its novel gene editing technologies, and expand its discovery platform....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Arbor Biotechnologies, are just a search away.